Evidence map›Paper›PMID 33209320›Full record

ArticleIUCrJ2020

Experimental phasing with vanadium and application to nucleotide-binding membrane proteins.

Kamel El Omari, Nada Mohamad, Kiran Bountra, Ramona Duman, Maria Romano, Katja Schlegel, Hok-Sau Kwong, Vitaliy Mykhaylyk, Claus Olesen, Jesper Vuust Moller and 3 more

Open access · goldAbstract read
In one paragraph

Article in IUCrJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Kamel El OmariDiamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom.ORCID https://orcid.org/0000-0003-3506-6045
Nada MohamadDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.ORCID https://orcid.org/0000-0002-0009-1358
Kiran BountraResearch Complex at Harwell, Rutherford Appleton Laboratory, Didcot OX11 0FA, United Kingdom.
Ramona DumanDiamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom.
Maria RomanoResearch Complex at Harwell, Rutherford Appleton Laboratory, Didcot OX11 0FA, United Kingdom.ORCID https://orcid.org/0000-0001-8901-3630
Katja SchlegelDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.ORCID https://orcid.org/0000-0002-3826-4824
Hok-Sau KwongResearch Complex at Harwell, Rutherford Appleton Laboratory, Didcot OX11 0FA, United Kingdom.
Vitaliy MykhaylykDiamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom.
Claus OlesenDepartment of Biomedicine, Aarhus University, Ole Worms Allé 8, DK-8000 Aarhus, Denmark.
Jesper Vuust MollerDepartment of Biomedicine, Aarhus University, Ole Worms Allé 8, DK-8000 Aarhus, Denmark.
Maike BublitzDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.ORCID https://orcid.org/0000-0003-3161-418X
Konstantinos BeisResearch Complex at Harwell, Rutherford Appleton Laboratory, Didcot OX11 0FA, United Kingdom.ORCID https://orcid.org/0000-0001-5727-4721
Armin WagnerDiamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, United Kingdom.ORCID https://orcid.org/0000-0001-8995-7324
Rutherford Appleton Laboratory · GBUniversity of Oxford · GBAarhus University · DK

Funding

Medical Research Council MR/N020103/1
6 · The paper itself

Abstract

The structure determination of soluble and membrane proteins can be hindered by the crystallographic phase problem, especially in the absence of a suitable homologous structure. Experimental phasing is the method of choice for novel structures; however, it often requires heavy-atom derivatization, which can be difficult and time-consuming. Here, a novel and rapid method to obtain experimental phases for protein structure determination by vanadium phasing is reported. Vanadate is a transition-state mimic of phosphoryl-transfer reactions and it has the advantage of binding specifically to the active site of numerous enzymes catalyzing this reaction. The applicability of vanadium phasing has been validated by determining the structures of three different protein-vanadium complexes, two of which are integral membrane proteins: the rabbit sarcoplasmic reticulum Ca

Indexed as

experimental phasingmembrane proteinsvanadium

Identifiers

PMID33209320
PMCPMC7642786
OpenAlexW3094214831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.